Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk
22 août 2023 09h00 HE
|
Myriad Genetics, Inc.
SALT LAKE CITY, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and Onsite Women’s Health, a leading national provider of...
ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk Assessments
04 avr. 2023 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., April 04, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new...
![Diet Doc Diet and Weight Loss Logo](/news-release/logo/387495/0/387495.jpg?lastModified=12%2F09%2F2016%2022%3A42%3A06&size=2)
Diet Doc Acknowledges and Supports Breast Cancer Awareness Month by Providing Customized Diet Plans that Burn Excess Fat Leading to a Reduced Breast Cancer Risk While Leaving Patients Looking and Feeling Better than Ever Before
07 oct. 2015 04h08 HE
|
Diet Doc Diet and Weight Loss
LOS ANGELES, Oct. 7, 2015 (GLOBE NEWSWIRE) -- Over 33,000 American women will receive the devastating breast cancer diagnosis this year. And, while there are some risk factors that are out of their...
![BREVAGen reclassified 64 percent of above average Gail risk subjects](http://www.globenewswire.com/fr/Attachment/LogoDisplay/269390?filename=269390.png&size=2)
CONTEMPORARY OBSTETRICS AND GYNECOLOGY OF DAYTON ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
30 sept. 2013 10h34 HE
|
Genetic Technologies Group
DAYTON, Ohio, Sept. 30, 2013 (GLOBE NEWSWIRE) -- Contemporary Obstetrics & Gynecology, part of the Providence Medical Group, today announced the availability of the BREVAGen™ predictive risk...
![BREVAGen reclassified 64 percent of above average Gail risk subjects](http://www.globenewswire.com/fr/Attachment/LogoDisplay/268032?filename=268032.png&size=2)
PEARL W. YEE, M.D. INC. OF SAN FRANCISCO ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
16 sept. 2013 10h08 HE
|
Genetic Technologies Group
SAN FRANCISCO, Sept. 16, 2013 (GLOBE NEWSWIRE) -- Pearl Yee, MD, FACOG and clinical professor at the University of California, San Francisco, is pleased to announce that her private practice, Pearl W....
![BREVAGen Logo_edit](http://www.globenewswire.com/fr/Attachment/LogoDisplay/265814?filename=265814.jpg&size=2)
OB/GYN ASSOCIATES IN LEWISBURG, PA ANNOUNCES THE AVAILABILITY OF STATE-OF-THE-ART BREAST CANCER RISK ASSESSMENT TEST
26 août 2013 13h06 HE
|
Genetic Technologies Group
SUNBURY, PA., Aug. 26, 2013 (GLOBE NEWSWIRE) -- Russell Stankiewicz, MD, FACOG, CCD, NMCP, is pleased to announce that OB/GYN Associates of Lewisburg, P.C. in Lewisburg, PA is now offering the...
![BREVAGen_reclassified](http://www.globenewswire.com/fr/Attachment/LogoDisplay/259900?filename=259900.jpg&size=2)
THE HEWITT CENTER FOR BREAST WELLNESS AT GRIFFIN HOSPITAL IN DERBY, CT LAUNCHES HIGH-RISK PROGRAM INCLUDING STATE-OF-THE-ART BREAST CANCER SCREENING OPTIONS
24 juin 2013 12h16 HE
|
Genetic Technologies Group
DERBY, Conn., June 24, 2013 (GLOBE NEWSWIRE) -- Denise Barajas, MD, medical director at The Hewitt Center for Breast Wellness in Derby, CT, has launched a high-risk breast cancer program that includes...
![BREVAGen chart](http://www.globenewswire.com/fr/Attachment/LogoDisplay/250915?filename=250915.jpg&size=2)
STUDY VALIDATES BREVAGen MORE ACCURATELY IDENTIFIES BREAST CANCER RISK LEADING TO INCREASED BREAST HEALTH COMPLIANCE
15 avr. 2013 12h06 HE
|
Genetic Technologies Group
CHARLOTTE, N.C., April 15, 2013 (GLOBE NEWSWIRE) -- Phenogen Sciences, Inc. recently presented study results demonstrating that BREVAGen™, a first-in-class, scientifically-validated predictive...